DrugPatentWatch Database Preview
TENUATE DOSPAN Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
When do Tenuate Dospan patents expire, and what generic alternatives are available?
Tenuate Dospan is a drug marketed by Teva Branded Pharm and is included in one NDA.
The generic ingredient in TENUATE DOSPAN is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Tenuate Dospan
A generic version of TENUATE DOSPAN was launched as diethylpropion hydrochloride by AVANTHI INC on December 12th, 2019.
Summary for TENUATE DOSPAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 4 |
| Bulk Api Vendors: | 42 |
| Patent Applications: | 1,975 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TENUATE DOSPAN at DailyMed |
Pharmacology for TENUATE DOSPAN
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Synonyms for TENUATE DOSPAN
| (-)-2-Diethylaminopropiophenone |
| (-)-Amfepramone |
| (+-)-diethylpropion |
| (+)-2-Diethylaminopropiophenone |
| (+)-Amfepramone |
| (+/-)-diethylpropion |
| 090D846 |
| 1-Phenyl-2-diethylamino-1-propanone |
| 1-Phenyl-2-diethylamino-1-propanone hydrochloride |
| 1-Phenyl-2-diethylaminopropanone-1 hydrochloride |
| 1-Propanone, 2-(diethylamino)-1-phenyl- |
| 1-Propanone, 2-(diethylamino)-1-phenyl-, (-)- |
| 1-Propanone, 2-(diethylamino)-1-phenyl-, (+)- |
| 1-Propanone, 2-(diethylamino)-1-phenyl-, hydrochloride |
| 134-80-5 |
| 2-(Diethylamino)-1-phenyl-1-propanone |
| 2-(Diethylamino)-1-phenyl-1-propanone # |
| 2-(Diethylamino)-1-phenyl-1-propanone Hydrochloride |
| 2-(diethylamino)-1-phenyl-propan-1-one hydrochloride |
| 2-(diethylamino)-1-phenylpropan-1-one |
| 2-(diethylamino)-1-phenylpropan-1-one hydrochloride |
| 2-(Diethylamino)propiophenone |
| 2-(Diethylamino)propiophenone hydrochloride |
| 2-Diethylaminopropiophenone |
| 2-Diethylaminopropiophenone hydrochloride |
| 39648-49-2 |
| 39648-50-5 |
| 4-14-00-00144 (Beilstein Handbook Reference) |
| 90-84-6 |
| AC-13099 |
| AC-16025 |
| AC1L1NUD |
| AC1L3M34 |
| Adiposon |
| AKOS015962206 |
| AKOS025401369 |
| alpha-Benzoyltriethylamine |
| alpha-Benzoyltriethylamine hydrochloride |
| alpha-Benzoyltriethylammonium chloride |
| alpha-Diethylaminopropiophenone |
| Amfepramon |
| Amfepramon hydrochloride |
| Amfepramone |
| Amfepramone (hydrochloride) |
| Amfepramone (INN) |
| Amfepramone [INN] |
| Amfepramone HCL |
| Amfepramone hydrochloride |
| Amfepramone, (-)- |
| Amfepramone, (+)- |
| Amfepramonum |
| Amfepramonum [INN-Latin] |
| Amphepramon |
| Amphepramone |
| Amphepramonum hydrochloride |
| AN-23092 |
| Anfamon |
| Anfepramona |
| Anfepramona [INN-Spanish] |
| Anorex |
| AOB5348 |
| API0005426 |
| AS-16865 |
| BRD-A37288617-003-01-4 |
| BRN 2804400 |
| C-46079 |
| C06954 |
| C13H19NO |
| C13H19NO.HCl |
| Cambridge id 5809497 |
| CAS-134-80-5 |
| CCG-220122 |
| Cegramine |
| CHEBI:4530 |
| CHEBI:643703 |
| CHEMBL1194666 |
| CHEMBL1693 |
| CS-4472 |
| D03801 |
| D07444 |
| Danylen |
| DB00937 |
| DEA No. 1610 |
| Derfon |
| Diethylcathinone |
| Diethylproion hydrochloride |
| DIETHYLPROPION |
| Diethylpropion (BAN) |
| Diethylpropion HCL |
| Diethylpropion Hydrochloride |
| Diethylpropion hydrochloride (USP) |
| Diethylpropion hydrochloride [USAN] |
| Diethylpropion hydrochloride [USP] |
| Diethylpropion hydrochloride solution, 1.0 mg/mL in methanol (with 1% 1 M HCl; as free base), certified reference material |
| Diethylpropion, (-)- |
| Diethylpropion, (+}- |
| DIETHYLPROPION, DONYLEN,DOBESIN |
| Diethylpropione |
| Diethylpropione hydrochloride |
| Dobesin |
| DSSTox_CID_27816 |
| DSSTox_GSID_47838 |
| DSSTox_RID_82580 |
| DTXSID4047838 |
| DTXSID6022929 |
| EINECS 202-019-1 |
| EINECS 205-156-5 |
| Fenyl-(1-diethylaminoethyl)keton |
| Fenyl-(1-diethylaminoethyl)keton [Czech] |
| Frekentine |
| GTPL7161 |
| HSDB 3059 |
| HY-B0981 |
| I535TOV6LY |
| Keramik |
| Keramin |
| Lineal-Rivo |
| LS-125137 |
| LS-125146 |
| Magrene |
| Magrex Retard |
| MCULE-2048650105 |
| MCULE-3905795013 |
| Menutil |
| MFCD00056154 |
| Moderatan |
| Modulor |
| NCGC00167475-01 |
| NCGC00167475-02 |
| Neobes |
| Nopropiophenone |
| Nu-Dispoz |
| Obesitex |
| P1A5AE6Q2R |
| Parabolin |
| Phepranon |
| Prefamone |
| Propiophenone, 2-(diethylamino)- |
| Propiophenone, 2-(diethylamino)-, hydrochloride |
| Propiophenone, 2-diethylamino- |
| rac Diethylpropion-d10 Hydrochloride |
| Regenon |
| Regenon hydrochloride |
| Reginon |
| SC-99119 |
| SCHEMBL15483 |
| SCHEMBL27330 |
| Silutin |
| SR-01000220674 |
| SR-01000220674-1 |
| SR-01000220674-2 |
| Tenapil |
| Tenuate |
| Tenuate (TN) |
| Tenuate hydrochloride |
| Tenuate-Dospan |
| Tepanil |
| Tepanil Ten-tab |
| Tox21_112479 |
| Tox21_112479_1 |
| Tylinal |
| UNII-I535TOV6LY |
| UNII-P1A5AE6Q2R |
| UR 1423 |
| XXEPPPIWZFICOJ-UHFFFAOYSA-N |
US Patents and Regulatory Information for TENUATE DOSPAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | TENUATE DOSPAN | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 012546-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
